Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Benchmarks provide a reference point to gauge portfolio performance and risk. This intro explains how comparing returns against a relevant benchmark clarifies decisions and helps align goals.
22,975 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Tesla’s 2026 year foundational growth centers on ramping four key initiatives that lay the groundwork for the next wa...
A major strategic move lands in Voyager Technologies’ lap as it closes the Astrobotic acquisition while securing a he...
Five stalwart Dividend Aristocrats continue to anchor retirement portfolios with rising payouts, steady cash flow, an...
Berkshire Hathaway’s long-running bets on Coca-Cola and American Express continue to pay off in 2025. This article br...
NVIDIA is expanding beyond chips into cloud AI infrastructure. This move signals a broader AI ecosystem pivot that co...
Young men are flocking to prediction markets for quick payouts and heightened excitement, but analysts warn the bets ...
Money decisions often feel emotional, but the right math can turn spending into a set of clear, actionable choices. T...
A thorough look at Novanta's Q1 2026 results and what they signal for novanta (novt) 2026 earnings. We break down rev...
Meta Platforms posted a strong Q1 beat as CEO Mark Zuckerberg outlined a sweeping AI roadmap. The plan centers on per...
A major bank CEO is signaling a bold shift: AI spending could reach trillions. This article explains what that means ...
Plug Power has captured attention as gross margins begin to improve after years of pressure. This article breaks down...